Search results for '**' (1629 products)
13 Oct 2021  |  Global
Companion Diagnostics-specific Advanced Staining and APLIS to Drive Market Growth
The Tissue Diagnostics (TDx) market is expected to reach $8,848.6 million in 2025, growing at a CAGR of 8.9% from 2020 to 2025. Advanced Staining and Anatomical Pathology Laboratory Information Management Systems (APLIS) will continue to grow at higher rates due to growing demand for personalized diagnosis and need for automation respectively. Wher...
USD 4,455.00 save 10 %
13 Oct 2021  |  North America
Future Growth Potential Enhanced by the Pandemic and Growth Opportunities in Chronic Disease Management
Chronic diseases have continued to rise in prevalence, and the costs of managing these and treating the complications arising from poor management cost the US healthcare system hundreds of billions of dollars each year. Clearly, physicians alone cannot control this rising challenge, and to ensure behaviour change, several tools are necessary to sup...
USD 4,455.00 save 10 %
20 Sep 2021  |  North America
Personalized Diagnostics and Increased Healthcare Investment to Drive Market Growth Post COVID-19 Pandemic
The change in reimbursement for diagnostic testing, pressure from PAMA, regulatory trends in Europe, demand for large-scale testing, shift to precision diagnostics, emerging companies, and evolving business models demand assessing portfolio, evaluating competitor strategies, and exploring opportunities for business growth. The competitive nature of...
13 Sep 2021  |  North America
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of ph...
03 Sep 2021  |  North America
Value-based Renal Care to be a Key Growth Area
The global prevalence of CKD is estimated to be about 9% to 10%. Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and mental ill hea...
31 Aug 2021  |  Global
Technology Developments Driving Transformational Growth in Treatment Modalities for Obstructive Lung Diseases
Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...
27 Aug 2021  |  North America
Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...
03 Aug 2021  |  North America
A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines
During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...
12 Aug 2021  |  North America
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
16 Aug 2021  |  North America
Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity
Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...